Earnings

Rocket Lab USA delivered what should have been a market-thrilling quarterly report, yet its shares defied expectations by trending downward....

Phathom Pharmaceuticals is demonstrating remarkable momentum in the market, fueled by unexpectedly robust quarterly earnings and significant clinical development milestones....

Rafael's stock is experiencing a severe downturn, driven by a combination of technical breakdowns, disappointing quarterly results, and intense selling...

In a surprising market reaction, Energous Corporation witnessed its stock decline following the announcement of what should have been celebratory...

Fuel Tech Inc. witnessed a dramatic after-hours selloff, with its stock price collapsing by 15.87% in response to its third-quarter...

Friday's trading session delivered a severe blow to Oxford Lane Capital shareholders as the stock plummeted to a fresh 52-week...

Biotechnology firm Ocugen Inc. finds itself navigating a critical juncture. While the company's latest earnings report revealed substantial revenue growth,...

The financial technology powerhouse Fiserv is confronting its most severe operational challenge in decades. A devastating earnings collapse in late...

Eli Lilly and Company has positioned itself for substantial expansion through a series of strategic developments announced in early November...

The biotechnology firm Lyra Therapeutics Inc finds itself navigating turbulent waters, with its equity valuation under severe pressure. A combination...